Antengene ATG-022 CLDN18.2 ADC Gets China Nod for Keytruda Combo in Gastric Cancer
CompanyDrug

Antengene ATG-022 CLDN18.2 ADC Gets China Nod for Keytruda Combo in Gastric Cancer

MSD MK-2214 Fast Track Alzheimer Data Positive
CompanyDrug

MSD MK-2214 Fast Track Alzheimer Data Positive

China Drug-Price Registration System Launches with First Batch of 10 Products
Policy / Regulatory

China Drug-Price Registration System Launches with First Batch of 10 Products

3SBio HK$3.1B Placement Funds R&D Pipeline for 705, 706, 008
CompanyDeals

3SBio HK$3.1B Placement Funds R&D Pipeline for 705, 706, 008

Generate GB-0895 Asthma Phase III Trials to Enroll 1,600 Patients
CompanyDrug

Generate GB-0895 Asthma Phase III Trials to Enroll 1,600 Patients

Henlius HLX14 Denosumab Biosimilar NDA Accepted by China CDE
CompanyDrug

Henlius HLX14 Denosumab Biosimilar NDA Accepted by China CDE

New-Radiomedicine Series-D Raises 800M Yuan for Radiopharmaceuticals
CompanyDeals

New-Radiomedicine Series-D Raises 800M Yuan for Radiopharmaceuticals

Kura ziftomenib Sale Triggers $135M Kyowa-Kirin Payment
CompanyDeals

Kura ziftomenib Sale Triggers $135M Kyowa-Kirin Payment

Roche cobas-liat Whooping-Cough Test Secures FDA Clearance
CompanyMedical Device

Roche cobas-liat Whooping-Cough Test Secures FDA Clearance

Henlius HLX37 Bispecific NMPA Approval Targets Advanced Solid Tumors
CompanyDrug

Henlius HLX37 Bispecific NMPA Approval Targets Advanced Solid Tumors

Leads-Biolabs LBL047 Bispecific Secures China IND Approval for SLE
CompanyDrug

Leads-Biolabs LBL047 Bispecific Secures China IND Approval for SLE

Shanghai Bao Pharma IPO HKEX Raises HK$1 Billion for Biotech Pipeline
CompanyDeals

Shanghai Bao Pharma IPO HKEX Raises HK$1 Billion for Biotech Pipeline